Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients

Annals of Intensive Care

Table 5 Comparison of clinical and biological variables at ICU admission between survivor and non-survivor septic patients

	Survivors 75	Non-survivors 25	p value
Sex (male/female)	43/32	18/7	0.06
Age, years (mean ± SD)	56.2 ± 19	64.6 ± 12	0.04
SAPS II, median (IQR)	41 (30–54)	65 (53–78)	<0.0001
SOFA, median (IQR)	7 (5–10)	10.5 (8–13)	<0.0001
Creatininemia, median (IQR), (μmol/L)	80 (32–103)	39 (20–68)	0.01
PCT, median (IQR), (ng/mL)	0.89 (0.20–11.4)	4.67 (1.89–24.8)	0.005
hsCRP, median (IQR), (mg/L)	95 (38–233)	150 (48–245)	0.24
Presepsin, median (IQR), (pg/mL)	871 (449–1828)	1734 (1014–3128)	0.0002
ICU length of stay, median (IQR), (days)	4 (2–11)	4 (2–10)	0.53

SAPS simplified acute physiology score, SOFA sequential organ failure assessment score, PCT procalcitonin, hsCRP high-sensitivity C-reactive protein
p: differences between survivor and non-survivor septic patients